RAD
Price sensitive
RAD Doses First Patient in RAD 402 Phase 1 Clinical Study
Radiopharm Theranostics Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in